MedPath

Study to Evaluate Satisfaction After Treatment With Kysse

Not Applicable
Completed
Conditions
Lip Augmentation
Interventions
Device: Hyaluronic acid
Registration Number
NCT03967444
Lead Sponsor
Galderma R&D
Brief Summary

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Kysse.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Signed and dated informed consent to participate in the study
  • Adult women and men who intend to undergo lip augmentation
Read More
Exclusion Criteria
  • Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics
  • Subjects with a previous implant other than HA in or near the intended treatment site
  • Participation in any other clinical study within three (3) months before treatment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Restylane Kysse with other HAHyaluronic acidHyaluronic acid
Restylane KysseHyaluronic acidHyaluronic acid
Primary Outcome Measures
NameTimeMethod
Assess Treatment With Restylane Kysse Using GAIS8 weeks after last treatment

The 5-grade Global Aesthetic Improvement Scale (GAIS) assess the appearance of the lips compared to pre-treatment. The rating is very much improved, much improved, improved, no change, or worse. Responders are those with a rating of at least improved.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Galderma Study Site

🇨🇦

Toronto, Canada

© Copyright 2025. All Rights Reserved by MedPath